Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Medtronic
Baxter
McKesson
Boehringer Ingelheim

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drug Price Trends for ESCITALOPRAM OXALATE

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for ESCITALOPRAM OXALATE

Average Pharmacy Cost for ESCITALOPRAM OXALATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ESCITALOPRAM OXALATE 5 MG/5 ML 65162-0705-88 0.36015 ML 2019-10-23
ESCITALOPRAM OXALATE 5 MG/5 ML 31722-0569-24 0.36015 ML 2019-10-23
ESCITALOPRAM OXALATE 5 MG/5 ML 51672-1348-01 0.36015 ML 2019-10-23
ESCITALOPRAM OXALATE 5 MG/5 ML 54838-0551-70 0.36015 ML 2019-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for ESCITALOPRAM OXALATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LEXAPRO 5MG TABLETS Allergan USA, Inc 00456-2005-01 100 987.07 9.87070 EACH 2018-09-30 - 2023-09-29 FSS
LEXAPRO 5MG TABLETS Allergan USA, Inc 00456-2005-01 100 666.20 6.66200 EACH 2019-01-01 - 2023-09-29 Big4
LEXAPRO 5MG TABLETS Allergan USA, Inc 00456-2005-01 100 987.07 9.87070 EACH 2019-01-01 - 2023-09-29 FSS
LEXAPRO 10MG TABLETS Allergan USA, Inc 00456-2010-01 100 549.78 5.49780 EACH 2018-09-30 - 2023-09-29 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Medtronic
Harvard Business School
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.